We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock

Delisted

SILK was delisted on the 16th of September, 2024.

101 hedge funds and large institutions have $859M invested in Silk Road Medical, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 15 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

677% more call options, than puts

Call options by funds: $101K | Put options by funds: $13K

267% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 15

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

2% more funds holding

Funds holding: 99101 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

18% less capital invested

Capital invested by funds: $1.05B → $859M (-$187M)

Holders
101
Holders Change
+2
Holders Change %
+2.02%
% of All Funds
2.21%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
21
Increased
55
Reduced
15
Closed
18
Calls
$101K
Puts
$13K
Net Calls
+$88K
Net Calls Change
+$88K
Name Holding Trade Value Shares
Change
Change in
Stake
WP
1
Warburg Pincus
New York
$241M -$191M -4,793,328 -39%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$88.6M +$98M +2,458,637 +635%
NVPX
3
Norwest Venture Partners XIII
California
$80.1M
BAMCO Inc
4
BAMCO Inc
New York
$40M +$38.5M +966,208 +366%
Wells Fargo
5
Wells Fargo
California
$35M +$37.8M +949,519 +748%
Jennison Associates
6
Jennison Associates
New York
$34M +$24.6M +617,337 +145%
AllianceBernstein
7
AllianceBernstein
Tennessee
$33.4M +$40.5M +1,016,105 +9,770%
DM
8
Deerfield Management
New York
$31.9M +$19.1M +480,450 +96%
Vanguard Group
9
Vanguard Group
Pennsylvania
$31.1M +$16.9M +425,371 +80%
BlackRock
10
BlackRock
New York
$30.9M +$24.5M +615,327 +184%
Victory Capital Management
11
Victory Capital Management
Texas
$22.5M +$26.7M +671,181 +3,529%
TCM
12
TimesSquare Capital Management
New York
$19.5M +$8.5M +213,402 +55%
Lord, Abbett & Co
13
Lord, Abbett & Co
New Jersey
$12.1M +$3.63M +91,183 +32%
SPPAM
14
Summit Partners Public Asset Management
Massachusetts
$11.9M +$14.5M +365,000 New
Invesco
15
Invesco
Georgia
$10.6M +$3.39M +85,000 +36%
GPP
16
Great Point Partners
Connecticut
$9.82M +$12M +301,979 New
Massachusetts Financial Services
17
Massachusetts Financial Services
Massachusetts
$8.97M -$41.5K -1,042 -0.4%
NHAS
18
Novo Holdings A/S
Denmark
$7.97M +$3.98M +100,000 +69%
RI
19
RTW Investments
New York
$7.96M +$836K +20,994 +9%
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$7.11M +$2.12M +53,323 +32%
American Century Companies
21
American Century Companies
Missouri
$6.86M +$3.77M +94,558 +81%
AI
22
Atom Investors
Texas
$6.71M +$8.22M +206,307 New
Kayne Anderson Rudnick Investment Management
23
Kayne Anderson Rudnick Investment Management
California
$6.35M +$2.07M +51,986 +36%
State Street
24
State Street
Massachusetts
$6.09M +$3.36M +84,321 +82%
Goldman Sachs
25
Goldman Sachs
New York
$5.32M +$210K +5,267 +3%

SILK Hedge Fund Activity: Q3 2019 in Review

101 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2019, worth a combined $859M — down 18% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SILK positions and 18 closed out — a net gain of 3 holders — while 55 added to existing stakes and 15 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $98M. The largest seller was Warburg Pincus, cutting an estimated $191M.

  • 101 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2019, up from 99 in Q2 2019.
  • Funds reported $859M of Silk Road Medical, Inc. Common Stock stock for Q3 2019, down 18% quarter-over-quarter.
  • 21 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2019 and 18 closed out, a net change of +3 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2019 was Janus Henderson Group, an estimated $98M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q3 2019 was Warburg Pincus, an estimated $191M sold.

Based on aggregated 13F filings for Q3 2019.